Rick Kapur

4.2k total citations · 1 hit paper
92 papers, 2.7k citations indexed

About

Rick Kapur is a scholar working on Hematology, Biochemistry and Immunology. According to data from OpenAlex, Rick Kapur has authored 92 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Hematology, 21 papers in Biochemistry and 21 papers in Immunology. Recurrent topics in Rick Kapur's work include Platelet Disorders and Treatments (49 papers), Blood groups and transfusion (37 papers) and Blood transfusion and management (21 papers). Rick Kapur is often cited by papers focused on Platelet Disorders and Treatments (49 papers), Blood groups and transfusion (37 papers) and Blood transfusion and management (21 papers). Rick Kapur collaborates with scholars based in Netherlands, Canada and Sweden. Rick Kapur's co-authors include John W. Semple, Anne Zufferey, Johan Rebetz, Gestur Vidarsson, Leendert Porcelijn, C. Ellen van der Schoot, Masja de Haas, Manfred Wuhrer, Éric Boilard and H Einarsdottir and has published in prestigious journals such as Journal of Clinical Investigation, Blood and The Journal of Immunology.

In The Last Decade

Rick Kapur

85 papers receiving 2.7k citations

Hit Papers

Pathogenesis and Therapeutic Mechanisms in Immune Thrombo... 2017 2026 2020 2023 2017 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rick Kapur Netherlands 28 1.3k 757 629 413 409 92 2.7k
Brian R. Curtis United States 34 2.3k 1.8× 845 1.1× 446 0.7× 422 1.0× 107 0.3× 124 3.9k
Alan H. Lazarus Canada 35 2.2k 1.7× 1.8k 2.4× 625 1.0× 138 0.3× 750 1.8× 117 4.3k
Daniel H. Ryan United States 21 616 0.5× 596 0.8× 589 0.9× 177 0.4× 438 1.1× 69 2.1k
Rosemary L. Sparrow Australia 31 779 0.6× 384 0.5× 391 0.6× 683 1.7× 87 0.2× 92 2.2k
J. G. A. Houbiers Netherlands 19 356 0.3× 755 1.0× 332 0.5× 733 1.8× 107 0.3× 33 2.2k
C. Mueller‐Eckhardt Germany 41 4.7k 3.6× 1.0k 1.4× 193 0.3× 274 0.7× 230 0.6× 155 6.0k
Paul Friese United States 22 1.4k 1.1× 770 1.0× 487 0.8× 84 0.2× 65 0.2× 35 2.6k
Katsuyasu Saigo Japan 20 609 0.5× 346 0.5× 380 0.6× 63 0.2× 238 0.6× 106 1.8k
Krasimir Kolev Hungary 24 776 0.6× 568 0.8× 369 0.6× 69 0.2× 94 0.2× 92 2.3k
Harvey R. Gralnick United States 35 2.0k 1.5× 432 0.6× 560 0.9× 100 0.2× 135 0.3× 92 3.8k

Countries citing papers authored by Rick Kapur

Since Specialization
Citations

This map shows the geographic impact of Rick Kapur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rick Kapur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rick Kapur more than expected).

Fields of papers citing papers by Rick Kapur

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rick Kapur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rick Kapur. The network helps show where Rick Kapur may publish in the future.

Co-authorship network of co-authors of Rick Kapur

This figure shows the co-authorship network connecting the top 25 collaborators of Rick Kapur. A scholar is included among the top collaborators of Rick Kapur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rick Kapur. Rick Kapur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bentlage, Arthur E. H., José M. de Pereda, Leendert Porcelijn, et al.. (2025). HPA-1a antibodies in FNAIT do not distinguish αvβ3 from αIIbβ3, and bind inactive integrins more strongly than active integrins. Blood. 146(18). 2189–2202.
2.
Netelenbos, Tanja, Marina Kartachova, Roger E. G. Schutgens, et al.. (2025). The ‘Stop TPO‐RA in ITP Patients’ study: Clinical and immune modulatory effects of romiplostim tapering. British Journal of Haematology. 206(6). 1743–1753.
3.
Xu, Xiuzhang, Wenjie Xia, Xin Ye, et al.. (2025). Inhibition of terminal complement complex formation alleviates murine antibody-mediated TRALI. Blood. 146(6). 759–764.
4.
Roelofs, Joris J. T. H., et al.. (2025). Platelet transfusion induces transfusion‐associated circulatory overload in rats with myocardial infarction. Transfusion. 65(7). 1251–1263. 1 indexed citations
6.
Rottenstreich, Amihai, et al.. (2024). Does anti‐HPA‐1a affect birthweight in fetal and neonatal alloimmune thrombocytopenia?. Pediatric Blood & Cancer. 71(4). e30835–e30835. 2 indexed citations
7.
Kapur, Rick, John W. Semple, & Alexander P. J. Vlaar. (2024). The importance of disrupting complement activation in acute lung injury. Journal of Clinical Investigation. 134(12). 1 indexed citations
8.
Xu, Xiuzhang, Wenjie Xia, Xin Ye, et al.. (2023). Mechanism and intervention of murine transfusion-related acute lung injury caused by anti-CD36 antibodies. JCI Insight. 8(6). 8 indexed citations
9.
Kapur, Rick. (2023). Intravenous immunoglobulins ameliorate thrombin‐related platelet functions in childhood immune thrombocytopenia. British Journal of Haematology. 201(6). 1019–1020. 2 indexed citations
10.
Velden, Saskia van der, Arthur E. H. Bentlage, Juk Yee Mok, et al.. (2023). Complement activation drives antibody-mediated transfusion-related acute lung injury via macrophage trafficking and formation of NETs. Blood. 143(1). 79–91. 19 indexed citations
12.
Pongrácz, Tamás, Juk Yee Mok, Wim J.E. van Esch, et al.. (2022). Altered Fc glycosylation of anti‐HLA alloantibodies in hemato‐oncological patients receiving platelet transfusions. Journal of Thrombosis and Haemostasis. 20(12). 3011–3025. 8 indexed citations
13.
Zwaginga, Jaap Jan, John W. Semple, Leendert Porcelijn, et al.. (2021). Platelets in ITP: Victims in Charge of Their Own Fate?. Cells. 10(11). 3235–3235. 18 indexed citations
14.
Winkelhorst, Dian, Hans J. Baelde, Lotte E. van der Meeren, et al.. (2021). Placental Complement Activation in Fetal and Neonatal Alloimmune Thrombocytopenia: An Observational Study. International Journal of Molecular Sciences. 22(13). 6763–6763. 10 indexed citations
15.
Velden, Saskia van der, Arthur E. H. Bentlage, Mads Delbo Larsen, et al.. (2020). Biological and structural characterization of murine TRALI antibody reveals increased Fc-mediated complement activation. Blood Advances. 4(16). 3875–3885. 11 indexed citations
16.
Kumpel, Belinda M., Radka Saldova, Carolien A. M. Koeleman, et al.. (2020). Anti-D monoclonal antibodies from 23 human and rodent cell lines display diverse IgG Fc-glycosylation profiles that determine their clinical efficacy. Scientific Reports. 10(1). 1464–1464. 16 indexed citations
17.
Kapur, Rick, Gopinath Kasetty, Johan Rebetz, Arne Egesten, & John W. Semple. (2019). Osteopontin mediates murine transfusion-related acute lung injury via stimulation of pulmonary neutrophil accumulation. Blood. 134(1). 74–84. 45 indexed citations
18.
Kapur, Rick, Rukhsana Aslam, Edwin R. Speck, Johan Rebetz, & John W. Semple. (2019). Thrombopoietin receptor agonist (TPO-RA) treatment raises platelet counts and reduces anti-platelet antibody levels in mice with immune thrombocytopenia (ITP). Platelets. 31(3). 399–402. 35 indexed citations
19.
Kapur, Rick, Johan Rebetz, Björn M. Hallström, et al.. (2018). Gastrointestinal microbiota contributes to the development of murine transfusion-related acute lung injury. Blood Advances. 2(13). 1651–1663. 43 indexed citations
20.
Kapur, Rick, H Einarsdottir, & Gestur Vidarsson. (2014). IgG-effector functions: “The Good, The Bad and The Ugly”. Immunology Letters. 160(2). 139–144. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026